| Literature DB >> 34183759 |
Shahar Cohen1, Shirly Partouche2,3, Michael Gurevich4, Vladimir Tennak4, Vadym Mezhybovsky4, Dmitry Azarov5, Sarit Soffer-Hirschberg6, Benny Hovav6, Hagit Niv-Drori7, Chana Weiss7, Adi Borovich8,9, Guy Cohen8, Avital Wertheimer8,9, Golan Shukrun10,11, Moshe Israeli12,13, Vered Yahalom9,14, Dorit Leshem-Lev3,15, Leor Perl9,15, Ran Kornowski9,15, Arnon Wiznitzer8,9, Ana Tobar7,9, Meora Feinmesser7,9, Eytan Mor9,16, Eli Atar6,9, Eviatar Nesher4.
Abstract
Whole organ perfusion decellularization has been proposed as a promising method to generate non-immunogenic organs from allogeneic and xenogeneic donors. However, the ability to recellularize organ scaffolds with multiple patient-specific cells in a spatially controlled manner remains challenging. Here, we propose that replacing donor endothelial cells alone, while keeping the rest of the organ viable and functional, is more technically feasible, and may offer a significant shortcut in the efforts to engineer transplantable organs. Vascular decellularization was achieved ex vivo, under controlled machine perfusion conditions, in various rat and porcine organs, including the kidneys, liver, lungs, heart, aorta, hind limbs, and pancreas. In addition, vascular decellularization of selected organs was performed in situ, within the donor body, achieving better control over the perfusion process. Human placenta-derived endothelial progenitor cells (EPCs) were used as immunologically-acceptable human cells to repopulate the luminal surface of de-endothelialized aorta (in vitro), kidneys, lungs and hind limbs (ex vivo). This study provides evidence that artificially generating vascular chimerism is feasible and could potentially pave the way for crossing the immunological barrier to xenotransplantation, as well as reducing the immunological burden of allogeneic grafts.Entities:
Year: 2021 PMID: 34183759 DOI: 10.1038/s41598-021-92823-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379